Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats

Molecular and Cellular Endocrinology

Volumn 289, Issue 1-2, 2008, Pages 85-93

  Trivedi, Ritu ^a   Kumar, Sudhir ^a   Kumar, Avinash ^a   Siddiqui, Jawed A ^a   Swarnkar, Gaurav ^a   Gupta, Varsha ^a   Kendurker, Amruta ^a   Dwivedi, Anil Kumar ^a   Romero, Jose R ^b   Chattopadhyay, Naibedya ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adipogenesis; Bioavailability; Bone strength; Flavonoids; Osteoprogenitor cells

Indexed keywords

ALKALINE PHOSPHATASE; KAEMPFEROL;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE MARROW CELL; BONE TURNOVER; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG URINE LEVEL; ENZYME ACTIVITY; FEMALE; FEMUR NECK; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SPRAGUE DAWLEY RAT; TIBIA; TREATMENT DURATION; VERTEBRA;

ADIPOCYTES; ADMINISTRATION, ORAL; ANIMALS; BONE DENSITY; BONE MARROW CELLS; CELL DIFFERENTIATION; FEMALE; FEMUR NECK; KAEMPFEROLS; LUMBAR VERTEBRAE; OSTEOBLASTS; OSTEOGENESIS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; TIBIA;

EID: 45049083944     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.02.027     Document Type: Article

References (30)

1. 2003. EGb 761: Ginkgo biloba extract, Ginkor. Drugs R D 4, 188-193.
2. Akcakaya H., Aroymak A., and Gokce S. A quantitative colorimetric method of measuring alkaline phosphatase activity in eukaryotic cell membranes. Cell Biol. Int. 31 2 (2007) 186-190
3. Arshad M., Sengupta S., Sharma S., Ghosh R., Sawlani V., and Singh M.M. In vitro anti-resorptive activity and prevention of ovariectomy-induced osteoporosis in female Sprague-Dawley rats by ormeloxifene, a selective estrogen receptor modulator. J. Steroid Biochem. Mol. Biol. 91 1/2 (2004) 67-78
4. Bagi C.M., Ammann P., Rizzoli R., and Miller S.C. Effect of estrogen deficiency on cancellous and cortical bone structure and strength of the femoral neck in rats. Calcif. Tissue Int. 61 4 (1997) 336-344
5. Chattopadhyay N., Quinn S.J., Kifor O., Ye C., and Brown E.M. The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation. Biochem. Pharmacol. 74 3 (2007) 438-447
6. Chen H.Q., Yao R., Han J., Deng L., and Li L. Effect of aging on the ability of growth and differentiation of rat bone marrow stromal cells. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 25 3 (2003) 244-249
7. Frost H.M., and Jee W.S. On the rat model of human osteopenias and osteoporoses. Bone Miner. 18 3 (1992) 227-236
8. Gregory J.S., Testi D., Stewart A., Undrill P.E., Reid D.M., and Aspden R.M. A method for assessment of the shape of the proximal femur and its relationship to osteoporotic hip fracture. Osteoporos. Int. 15 1 (2004) 5-11
9. Heim M., Johnson J., Boess F., Bendik I., Weber P., Hunziker W., and Fluhmann B. Phytanic acid, a natural peroxisome proliferator-activated receptor (PPAR) agonist, regulates glucose metabolism in rat primary hepatocytes. FASEB J. 16 7 (2002) 718-720
10. Horcajada-Molteni M.N., Crespy V., Coxam V., Davicco M.J., Remesy C., and Barlet J.P. Rutin inhibits ovariectomy-induced osteopenia in rats. J. Bone Miner. Res. 15 11 (2000) 2251-2258
11. Kalu D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15 3 (1991) 175-191
12. Kim H., Iwasaki K., Miyake T., Shiozawa T., Nozaki S., and Yajima K. Changes in bone turnover markers during 14-day 6 degrees head-down bed rest. J. Bone Miner. Metab. 21 5 (2003) 311-315
13. Lee Y.B., Lee H.J., Kim K.S., Lee J.Y., Nam S.Y., Cheon S.H., and Sohn H.S. Evaluation of the preventive effect of isoflavone extract on bone loss in ovariectomized rats. Biosci. Biotechnol. Biochem. 68 5 (2004) 1040-1045
14. Liu Z., and Hu M. Natural polyphenol disposition via coupled metabolic pathways. Expert Opin. Drug Metab. Toxicol. 3 3 (2007) 389-406
15. Lotito S.B., and Frei B. Dietary flavonoids attenuate tumor necrosis factor alpha-induced adhesion molecule expression in human aortic endothelial cells. Structure-function relationships and activity after first pass metabolism. J. Biol. Chem. 281 48 (2006) 37102-37110
16. Maniatopoulos C., Sodek J., and Melcher A.H. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res. 254 2 (1988) 317-330
17. Mosekilde L., Danielsen C.C., and Knudsen U.B. The effect of aging and ovariectomy on the vertebral bone mass and biomechanical properties of mature rats. Bone 14 1 (1993) 1-6
18. Nuttall M.E., Patton A.J., Olivera D.L., Nadeau D.P., and Gowen M. Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. J. Bone Miner. Res. 13 3 (1998) 371-382
19. Pang J.L., Ricupero D.A., Huang S., Fatma N., Singh D.P., Romero J.R., and Chattopadhyay N. Differential activity of kaempferol and quercetin in attenuating tumor necrosis factor receptor family signaling in bone cells. Biochem. Pharmacol. 71 6 (2006) 818-826
20. Park S.R., Oreffo R.O., and Triffitt J.T. Interconversion potential of cloned human marrow adipocytes in vitro. Bone 24 6 (1999) 549-554
21. Pastoureau P., Chomel A., and Bonnet J. Specific evaluation of localized bone mass and bone loss in the rat using dual-energy X-ray absorptiometry subregional analysis. Osteoporos. Int. 5 3 (1995) 143-149
22. Prabhakar U., James I.E., Dodds R.A., Lee-Rykaczewski E., Rieman D.J., Lipshutz D., Trulli S., Jonak Z., Tan K.B., Drake F.H., and Gowen M. A novel human bone marrow stroma-derived cell line TF274 is highly osteogenic in vitro and in vivo. Calcif. Tissue Int. 63 3 (1998) 214-220
23. Prouillet C., Maziere J.C., Maziere C., Wattel A., Brazier M., and Kamel S. Stimulatory effect of naturally occurring flavonols quercetin and kaempferol on alkaline phosphatase activity in MG-63 human osteoblasts through ERK and estrogen receptor pathway. Biochem. Pharmacol. 67 7 (2004) 1307-1313
24. Scalbert A., Manach C., Morand C., Remesy C., and Jimenez L. Dietary polyphenols and the prevention of diseases. Crit. Rev Food Sci. Nutr. 45 4 (2005) 287-306
25. Seeman E. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?. Bone 41 3 (2007) 308-317
26. Stroheker T., Pinnert M.F., Picard K., Chagnon M.C., and Canivenc-Lavier M.C. Estrogenic effects of apigenin, kaempferol and bisphenol A in immature Wistar female rats and in MCF-7 cells. IARC Sci. Publ. 156 (2002) 413-414
27. Walle T., Ta N., Kawamori T., Wen X., Tsuji P.A., and Walle U.K. Cancer chemopreventive properties of orally bioavailable flavonoids-methylated versus unmethylated flavones. Biochem. Pharmacol. 73 9 (2007) 1288-1296
28. Wattel A., Kamel S., Mentaverri R., Lorget F., Prouillet C., Petit J.P., Fardelonne P., and Brazier M. Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorption. Biochem. Pharmacol. 65 1 (2003) 35-42
29. Wong G.L., and Cohn D.V. Target cells in bone for parathormone and calcitonin are different: enrichment for each cell type by sequential digestion of mouse calvaria and selective adhesion to polymeric surfaces. Proc. Natl. Acad. Sci. U.S.A. 72 8 (1975) 3167-3171
30. Wronski T.J., Dann L.M., Scott K.S., and Cintron M. Long-term effects of ovariectomy and aging on the rat skeleton. Calcif. Tissue Int. 45 6 (1989) 360-366